New targeted drug shows promise for Hard-to-Treat cancers
NCT ID NCT03093116
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called repotrectinib in people with advanced solid tumors that have certain gene changes (ALK, ROS1, or NTRK). The trial has two parts: first, finding a safe dose, and second, seeing how well the drug shrinks tumors. About 500 adults with advanced cancers that have not responded to other treatments are being enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- repotrectinib (TPX-0005) capsules
- What this could lead to
- If successful, this could lead to a new targeted treatment option for people with advanced solid tumors that have specific genetic changes (ALK, ROS1, or NTRK).
- What could go wrong
- This is an early phase 1/2 trial, so safety and effectiveness are not yet proven. It may not work for all participants, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR WITH NTRK1 REARRANGEMENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anhui Provincial Hospital
RECRUITINGHefei, 230001, China
-
Asan Medical Center
RECRUITINGSeoul, 05505, South Korea
-
Baptist Memorial Hospital Baptist Cancer Center
RECRUITINGMemphis, Tennessee, 38120, United States
-
Beijing Cancer hospital
RECRUITINGBeijing, Beijing Municipality, 100142, China
-
Centre Antoine-Lacassagne
RECRUITINGNice, 06189, France
-
Centre Georges-Francois Leclerc
RECRUITINGDijon, 21079, France
-
Centre Hospitalier Universitarie Grenoble Alpes (Chuga)
RECRUITINGGrenoble, 38043, France
-
Centro di Riferimento Oncologico
RECRUITINGPordenone, 33081, Italy
-
Chonnam National University Hwasun Hospital
RECRUITINGHwasun-eup, Hwasun-gun, Jeollanam-do, 519-763, South Korea
-
Chris O'Brien LifeHouse
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Daping Hospital, the Third Affiliated Hospital of Third Military Medical University /Cancer Center
RECRUITINGDaping, Chongqing Municipality, 00000, China
-
Ehime University Hospital
RECRUITINGTōon, Ehime, 791-0295, Japan
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, MI, 20133, Italy
-
Guangdong Provincial People'S Hospital
RECRUITINGGuangzhou, Guangdong, 510120, China
-
Henan Cancer Hospital/The 1st pneumology department
RECRUITINGZhengzhou, 00000, China
-
Hokkaido University Hospital
RECRUITINGSapporo, Hokkaido, 0608648, Japan
-
Hospital Universitario HM Sanchinarro CIOCC
RECRUITINGMadrid, 28050, Spain
-
Hospital Unversitario Val D'Hebrón
RECRUITINGBarcelona, 8035, Spain
-
Hunan Cancer Hospital-thoracic oncology II
RECRUITINGChangsha, Hunan, 410013, China
-
IRCCS Istituto Regina Elena Oncologia Medica 2
RECRUITINGRoma, 144, Italy
-
Institute Gustave Roussy
RECRUITINGVillejuif, 98405, France
-
Jilin Cancer Hospital/Medical Oncology Department
RECRUITINGChangchun, Jilin, 130012, China
-
Jilin Cancer Hospital/Medical Oncology Department
RECRUITINGChangchun, Jilin, 130012, China
-
Kanagawa cancer center
RECRUITINGYokohama, Kanagawa, 2418515, Japan
-
Liaoning Cancer Hospital
RECRUITINGShenyang, Liaoning, 110801, China
-
Local Institution - 1001
COMPLETEDOrange, California, 92868, United States
-
Local Institution - 1002
ACTIVE_NOT_RECRUITINGNew York, New York, 10065, United States
-
Local Institution - 1003
COMPLETEDAurora, Colorado, 80045, United States
-
Local Institution - 1004
COMPLETEDBoston, Massachusetts, 02214, United States
-
Local Institution - 2101
COMPLETEDOrange, California, 92868, United States
-
Local Institution - 2102
COMPLETEDNew York, New York, 10065, United States
-
Local Institution - 2103
COMPLETEDAurora, Colorado, 80045, United States
-
Local Institution - 2105
COMPLETEDAnn Arbor, Michigan, 48109, United States
-
Local Institution - 2106
COMPLETEDWashington D.C., District of Columbia, 20007, United States
-
Local Institution - 2107
COMPLETEDSeattle, Washington, 98109, United States
-
Local Institution - 2108
COMPLETEDPhiladelphia, Pennsylvania, 19111-2497, United States
-
Local Institution - 2109
COMPLETEDCleveland, Ohio, 44195, United States
-
Local Institution - 2110
COMPLETEDWashington D.C., District of Columbia, 20016, United States
-
Local Institution - 2111
COMPLETEDDetroit, Michigan, 48201, United States
-
Local Institution - 2112
COMPLETEDCanton, Ohio, 44718, United States
-
Local Institution - 2113
COMPLETEDTampa, Florida, 33612, United States
-
Local Institution - 2114
COMPLETEDLa Jolla, California, 92093, United States
-
Local Institution - 2116
NOT_YET_RECRUITINGNew Orleans, Louisiana, 70121, United States
-
Local Institution - 2117
COMPLETEDNew York, New York, 10016, United States
-
Local Institution - 2119
COMPLETEDToledo, Ohio, 43614, United States
-
Local Institution - 2120
COMPLETEDGlendale, California, 91206, United States
-
Local Institution - 2121
COMPLETEDLong Beach, California, 90813, United States
-
Local Institution - 2122
COMPLETEDNew Brunswick, New Jersey, 08901, United States
-
Local Institution - 2127
COMPLETEDHouston, Texas, 77030, United States
-
Local Institution - 2129
COMPLETEDDuarte, California, 91010, United States
-
Local Institution - 2131
COMPLETEDBoston, Massachusetts, 02215, United States
-
Local Institution - 2132
COMPLETEDSaint Paul, Minnesota, 55101, United States
-
Local Institution - 2133
COMPLETEDBaltimore, Maryland, 21210, United States
-
Local Institution - 2134
COMPLETEDColumbus, Georgia, 31904, United States
-
Local Institution - 2136
WITHDRAWNLa Jolla, California, 92037, United States
-
Local Institution - 2137
COMPLETEDFairfax, Virginia, 22031, United States
-
Local Institution - 2140
COMPLETEDDetroit, Michigan, 48202-2608, United States
-
Local Institution - 2141
WITHDRAWNTacoma, Washington, 98405, United States
-
Local Institution - 2142
COMPLETEDPeoria, Illinois, 61615, United States
-
Local Institution - 2143
COMPLETEDCincinnati, Ohio, 45220, United States
-
Local Institution - 2144
COMPLETEDGoldsboro, North Carolina, 27534, United States
-
Local Institution - 2145
COMPLETEDAppleton, Wisconsin, 54911, United States
-
Local Institution - 2146
COMPLETEDKingwood, Texas, 77339, United States
-
Local Institution - 2147
COMPLETEDBolivar, Missouri, 65613, United States
-
Local Institution - 2201
COMPLETEDToronto, Ontario, M5G 2M9, Canada
-
Local Institution - 2202
COMPLETEDEdmonton, Alberta, T6G 1Z2, Canada
-
Local Institution - 2203
COMPLETEDOntario, L6R 37R, Canada
-
Local Institution - 2204
COMPLETEDOttawa, K1H 8L6, Canada
-
Local Institution - 2205
WITHDRAWNVancouver, British Columbia, V5Z 4E7, Canada
-
Local Institution - 3001
COMPLETEDSeoul, 03080, South Korea
-
Local Institution - 3002
COMPLETEDSeoul, Seodaemun-gu, 03722, South Korea
-
Local Institution - 3002
WITHDRAWNSeoul, Seoul Teugbyeolsi, 03080, South Korea
-
Local Institution - 3003
COMPLETEDSeoul, Gangnam-gu, 06351, South Korea
-
Local Institution - 3301
COMPLETEDEast Melbourne, 3002, Australia
-
Local Institution - 4102
COMPLETEDBarcelona, 08028, Spain
-
Local Institution - 4103
COMPLETEDMadrid, 28041, Spain
-
Local Institution - 4106
COMPLETEDMadrid, 28033, Spain
-
Local Institution - 4107
COMPLETEDValencia, 46009, Spain
-
Local Institution - 4108
COMPLETEDPamplona, 31008, Spain
-
Local Institution - 4201
COMPLETEDMarseille, Bouches-du-Rhône, 13005, France
-
Local Institution - 4203
COMPLETEDSaint-Mandé, 94163, France
-
Local Institution - 4207
COMPLETEDBrest, 29200, France
-
Local Institution - 4208
COMPLETEDPoitiers, 86000, France
-
Local Institution - 4302
COMPLETEDTerni, 05100, Italy
-
Local Institution - 4304
NOT_YET_RECRUITINGRavenna, 48121, Italy
-
Local Institution - 4305
COMPLETEDReggio Emilia, 42123, Italy
-
Local Institution - 4306
COMPLETEDMilan, 20122, Italy
-
Local Institution - 4307
WITHDRAWNPalermo, 90146, Italy
-
Local Institution - 4401
COMPLETEDLondon, SW3 6JJ, United Kingdom
-
Local Institution - 4402
COMPLETEDLondon, W12 OHS, United Kingdom
-
Local Institution - 4403
COMPLETEDManchester, M20 4BX, United Kingdom
-
Local Institution - 4404
COMPLETEDLondon, W1G 6AD, United Kingdom
-
Local Institution - 4405
COMPLETEDSutton, SM2 5PT, United Kingdom
-
Local Institution - 4501
COMPLETEDGroningen, 9713 GZ, Netherlands
-
Local Institution - 4502
COMPLETEDAmsterdam, 1066 CX, Netherlands
-
Local Institution - 4602
COMPLETEDWarsaw, 02-781, Poland
-
Local Institution - 4603
COMPLETEDSzczecin, 70-784, Poland
-
Local Institution - 4604
COMPLETEDLublin, 20-609, Poland
-
Local Institution - 4605
COMPLETEDPoznan, 60-693, Poland
-
Local Institution - 4701
COMPLETEDCologne, 50937, Germany
-
Local Institution - 4702
COMPLETEDHeidelberg, 69120, Germany
-
Local Institution - 4703
COMPLETEDDresden, 01307, Germany
-
Local Institution - 4704
COMPLETEDBerlin, 13125, Germany
-
Local Institution - 4801
COMPLETEDLeuven, 3000, Belgium
-
Local Institution - 4802
COMPLETEDAntwerp, 2650, Belgium
-
Local Institution - 4901
COMPLETEDCopenhagen, 2100, Denmark
-
Local Institution - 5101
COMPLETEDBudapest, 1083, Hungary
-
Local Institution - 5103
COMPLETEDBudapest, 1121, Hungary
-
Local Institution - 6103
COMPLETEDAdelaide, South Australia, 5042, Australia
-
Local Institution - 6201
ACTIVE_NOT_RECRUITINGTaiepi, 100, Taiwan
-
Local Institution - 6202
COMPLETEDTaipei, 10449, Taiwan
-
Local Institution - 6203
ACTIVE_NOT_RECRUITINGTainan, 704, Taiwan
-
Local Institution - 6304
COMPLETEDSeoul, 06591, South Korea
-
Local Institution - 6306
COMPLETEDCheongju-si, 28644, South Korea
-
Local Institution - 6307
COMPLETEDSeoul, 05030, South Korea
-
Local Institution - 6501
ACTIVE_NOT_RECRUITINGHong Kong, Hong Kong
-
Local Institution - 6502
ACTIVE_NOT_RECRUITINGHong Kong, 0, Hong Kong
-
Local Institution - 6503
ACTIVE_NOT_RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Local Institution - 6504
ACTIVE_NOT_RECRUITINGShatin, HONG KONG, 999077, China
-
Local Institution - 6505
ACTIVE_NOT_RECRUITINGShenzhen, Guangdong, 518053, China
-
Local Institution - 6702
COMPLETEDBeijing, Beijing Municipality, 100021, China
-
Local Institution - 6705
COMPLETEDChangsha, Hunan, 410011, China
-
Local Institution - 6710
COMPLETEDWuhan, Hubei, 430022, China
-
Local Institution - 6719
COMPLETEDFuzhou, Fujian, 000000, China
-
Local Institution - 6725
COMPLETEDHangzhou, Zhejiang, 310016, China
-
Local Institution - 6733
COMPLETEDGuangzhou, Guangdong, 510120, China
-
Local Institution - 6748
COMPLETEDNanjing, Jiangsu, 210008, China
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Massachusetts General Hospital,
RECRUITINGBoston, Massachusetts, 02114, United States
-
Memorial Healthcare System
RECRUITINGHollywood, Florida, 33021, United States
-
Nagoya University Hospital
RECRUITINGNagoya, 466-8560, Japan
-
National Cancer Center Hospital East
RECRUITINGKashiwa, 277-8577, Japan
-
National Cancer Center Hospital.
RECRUITINGChuo-ku, Tokyo, 1040045, Japan
-
National Cancer Center Singapore
RECRUITINGSingapore, 169610, Singapore
-
National University Hospital
RECRUITINGSingapore, 119074, Singapore
-
Osaka City General Hospital
RECRUITINGOsaka, Osaka, 5340021, Japan
-
Osaka International Cancer institute
RECRUITINGOsaka, 5418567, Japan
-
Ośrodek Badań Klinicznych Wczesnych Faz, Uniwersyteckie Centrum Kliniczne
RECRUITINGGdansk, 80-214, Poland
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, Victoria, 3000, Australia
-
START Madrid-FJD
RECRUITINGMadrid, 28040, Spain
-
Samsung Medical Center
RECRUITINGSeoul, Seoul-teukbyeolsi [Seoul], 06351, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, Seoul-teukbyeolsi [Seoul], 03080, South Korea
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
-
Shanxi Bethune Hospital
RECRUITINGTaiyuan, Shanxi, 030032, China
-
Sichuan Cancer Hospital/Medical Oncology Department
RECRUITINGChengdu, Sichuan, 00000, China
-
St Joseph Heritage Healthcare
RECRUITINGSanta Rosa, California, 95403, United States
-
Tangdu Hospital
RECRUITINGXi'an, Shan3xi, 710038, China
-
The Affiliated Tumor Hospital of Harbin Medical University
RECRUITINGHarbin, Heilongjiang, 150081, China
-
The First Affiliated Hospital - Zhejiang University School of Medicine
RECRUITINGHangzhou, 310003, China
-
The First Affiliated hospital of Xiamen University-oncology
RECRUITINGXiamen, Fujian, 361003, China
-
The First Hospital Affiliated To AMU - Southwest Hospital
RECRUITINGChongqing, Sichuan, 400030, China
-
The Ohio State University Wexner Medical Center
RECRUITINGColumbus, Ohio, 43210, United States
-
The Third Xiangya Hospital of Central South University/Department of Respiratory and Critical Care Medicine
RECRUITINGChangsha, 00000, China
-
The first hospital of Jilin university-Oncology Department
RECRUITINGChangchun, Jilin, 130021, China
-
Tottori University Hospital
RECRUITINGYonago, Tottori, 683-8504, Japan
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
-
University Cancer and Blood Center
RECRUITINGAthens, Georgia, 30607, United States
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
-
Washington University Infusion Center Pharmacy
RECRUITINGSt Louis, Missouri, 63110, United States
-
Weifang People's Hospital/Medical Oncology Department
RECRUITINGWeifang, 00000, China
-
West China Hospital Sichuan University/Lung cancer center
RECRUITINGChengdu, 00000, China
-
XuZhou Central Hospital/Oncology Department
RECRUITINGXuzhou, Jiangsu, 00000, China
-
Yonsei University Health System, Severance Hospital
RECRUITINGSeoul, 03722, South Korea
-
Zhejiang Cancer Hospital-Oncology
RECRUITINGHangzhou, Zhejiang, 310022, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Can your own immune cells fight advanced cancer?
- Can a radioactive antibody light up hidden cancers on PET scans?
- Blood test may let cancer patients take safe breaks from immunotherapy
- Off-the-Shelf cell therapy takes on Hard-to-Treat cancers
- New drug duo aims to reboot immune attack on Hard-to-Treat cancers